Navigation Links
Effective HIV control may depend on viral protein targeted by immune cells

An effective response of the immune system’s ‘killer?T cells against infection with HIV may depend on exactly which viral protein is targeted, according to an international group of researchers. A new study finds that HIV-infected individuals in whom virus-specific CD8 T cells are targeted against the Gag protein have lower viral levels than do those with CD8 responses directed against other viral proteins. The report from the Partners AIDS Research Center at Massachusetts General Hospital (PARC-MGH), the University of Oxford and University of KwaZulu-Natal in South Africa is receiving early online release in Nature Medicine.

"Understanding which immune responses are effective in control of HIV is of critical importance in vaccine development," says Philip Goulder, MD, PhD, of PARC-MGH and Oxford, the senior author of the study. "Previous approaches have focused on a ‘more is better?approach, seeking to generate responses against a broad range of viral proteins, but these results challenge that dogma."

While many strategies for developing a vaccine to control HIV focus on the activity of the CD8 T lymphocytes that recognize and destroy virus-infected CD4 T cells, the fact that even patients in the last stages of AIDS can have measurable CD8 responses indicates that those responses are not always effective. To investigate how variations in CD8 response alter the ability to control HIV, the research team enrolled almost 600 South African patients who had not yet been treated for their HIV infections.

The researchers comprehensively mapped the CD8 responses against all viral proteins and also investigated whether the versions of HLA Class I molecules involved in the immune system’s recognition of HIV protein fragments made a difference. When new viruses are produced within an infected cell, Class I molecules grab viral fragments and display them at the cell surface, thereby alerting CD8 cells that the cell has been infected and shoul
'"/>

Source:Massachusetts General Hospital


Page: 1 2

Related biology news :

1. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
2. Effective Cancer Treatments Follow The Clock
3. FDA Works To Speed The Advent Of New, More Effective Personalized Medicines
4. Fungus Effective Against Winged Termites
5. NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma
6. Effective, safe anthrax vaccine can be grown in tobacco plants
7. Ancient olfaction protein is shared by many bugs, offering new pest control target
8. Gene variations explain drug dose required to control seizures
9. U-M scientists find genes that control growth of common skin cancer
10. Scientists discuss improved biopesticides for locust control in West Africa
11. Insight into natural cholesterol control suggests novel cholesterol-lowering therapy

Post Your Comments:
(Date:11/24/2009)... , This release is available in Spanish . ,...re higher levels of inflammatory substances in the...eight; as shown by a research project of the Unive...Soto, a scientist at the School of Pharmacy. , T...mic study in relation to the control of body weigh...
(Date:11/23/2009)... , Washington, D.C. The community-associated str...g bacteria resistant to most common antibioticspos...wn and is making its way into hospitals, according...ectious Diseases . , The new threat is easily p...blic places and has increased the overall burden o...
(Date:11/23/2009)... , TORONTO, November 23, 2009 - The time of day...ording to a new paper produced by a research team ...oronto Scarborough,s vice-principal for research a...s biology at the St. George campus. , Capitali...f the poplar tree, the research team examined how ...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3American Otological Society 2009 Recipient For the 26quot 3BAward of Merit 26quot 3B Goes to Dr William H Lippy of Warren Ohio 48549 1American Otological Society 2009 Recipient For the 26quot 3BAward of Merit 26quot 3B Goes to Dr William H Lippy of Warren Ohio 48549 2Snoring pregnant women at higher risk for gestational diabetes 48547 1Snoring pregnant women at higher risk for gestational diabetes 48547 2
...ers have determined that the presence of the rare ... this increase to the consumption of refined plati...s, the equipment commonly installed in cars to red...uring platinum refinement and also during the norm...ly through the atmosphere. , While osmium is foun...
... offered by the green economy in the current econo...ee leading experts in the fields of economics and ...s Grantham Research Centre, Professor Paul Ekins o... the ESRC,s Centre for Economic Performance. ,Is...me traditional, and environmentally unfriendly, in...
..., a student in the MD/PhD program at LSU Health Sc...d Johnson Research Award in Endocrinology and Meta...e 2009 Experimental Biology Meeting April 18-22 in...or $500, is intended to recognize the graduate stu...s the best abstract for research in the area of En...
Other Biology News:Increasing levels of rare element found worldwide 2Saving the economy and saving the planet 2
(Date:11/24/2009)...alth care employment grew by 29,000 jobs in Octob...sistent growth during the U.S. recession. However,..., and health systems are coming closer to having t...administrators. , (Vocus)...nued growing in October despite the shedding of jo...
(Date:11/24/2009)...lif., Nov. 24 NeurogesX,...y focused on developing and commercializing novel ...thony DiTonno, President and Chief Executive Offic...er Jaffray Health Care Conference, to be held Dece... York, New York. ,, Mr. DiTonno and Stephen Gh...
(Date:11/24/2009)... FBI recently approved the Promega PowerPlex 16 HS...r generating DNA records for the National DNA Inde...SA (PRWEB) -- The FBI recently approved the Promeg...ories participating in, or generating DNA records ...rrently contains more than seven million profiles ...
(Date:11/24/2009)...mber 24 Shire plc (LSE: ...rmaceutical company, today,announced that it has s...r,velaglucerase alfa, the company,s enzyme replace...ype 1 Gaucher disease. This is the third marketing...submitted, with previous,submissions in the United...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...liance, the,non- profit organization that manages ...sing a grant program that enabled over ninety prof...employment in the life sciences and,biotechnology-...e Workforce Alliance,s expiring Biotechnology Trai...bor,s High Growth Job Training,Initiative in 2004 ...
...iles,Transnational Corp. today announced the expan...atories and Clinical Development Services (CDS) un...ss in China., The new consolidated Quintiles Chin...pace, is located at Sun Dong Ann Plaza in Beijing,... Peking Union Medical College,Hospital (PUMCH). Th...
...rug,and diagnostic discovery company, announced to...ic partnership with bioMerieux in the field of,can... ExonHit will gain,commercial rights on the diagno...oMerieux will have a greater flexibility to initia...ield., The partnership, initiated in October 2005...
Other Biology Technology:Workforce Alliance Concludes Three-Year Biotech Training Program 2Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility 2ExonHit and bioMerieux Amend Their Strategic Partnership 2ExonHit and bioMerieux Amend Their Strategic Partnership 3
TBS Buffer from Invitrogen
Western Blot from Covance Research Products, Inc
...OneSTrEP Protein Interaction Kit provides an extre...ate intact protein complexes. Unlike other systems...ification steps, this system takes advantage of th...r fast protein purification under physiological co...
Streptavidin, PE conjugated/tagged from Invitrogen
Biology Products: